4th Quarter - Termination Amendment

VENN STRATEGIES for PHRMA

Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 17, 2018

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Termination Dec 19, 2018 $60,000 Replaced
4th Quarter - Termination Amendment (this page) Jan 4, 2019 $20,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to access to bio-pharmaceuticals.

LobbyistCovered position, as disclosed
NATASCHA CUMBERLIDGE —
PETER GOELZ —
MICHELLE SEGER —
STEPHANIE SILVERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.